Effect of Spironolactone on COVID-19 in Patients With Underlying Liver Cirrhosis: A Nationwide Case-Control Study in South Korea

Frontiers in Medicine

Minkook Son¹  Dongsub Jeon²  Jonggi Choi² 

[1] Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, South Korea;Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea;

关键词: coronavirus disease 2019;    spironolactone;    liver cirrhosis;    infectivity;    susceptibility;   

DOI  :  10.3389/fmed.2021.629176

来源: Frontiers

【 授权许可】

CC BY